Finch

Scioto Biosciences

This company develops live bacterial therapeutics and delivery platforms to treat patients with autism, gastrointestinal disorders and neonatal intestinal conditions.

Vedanta Biosciences

This company develops microbiome-based oral therapies using bacterial consortia to treat patients with gastrointestinal and immune-mediated diseases.

Enterbiotix

This company develops orally administered microbiome therapeutics to treat patients with gastrointestinal conditions including irritable bowel syndrome and liver cirrhosis.

KOBIOLABS

This company develops microbiome-derived therapeutics and live biotherapeutic products for patients with immune, metabolic, neurological and gastrointestinal diseases.

Microbiotica

This company develops live bacterial therapeutics and biomarkers for patients with inflammatory bowel disease and advanced melanoma.

Human Biome

This biotechnology firm develops gut microbiota-based biotherapeutics and fecal microbiota transplantation preparations for medical professionals treating gastrointestinal infections and antibiotic resistance.

Bloom Science

This biotechnology company develops microbiome-based oral therapeutics for patients with rare neurological conditions and metabolic disorders like obesity and epilepsy.

MRM Health

This biopharmaceutical company develops microbiome-based live biotherapeutic products for patients with chronic inflammatory diseases and immune-oncology conditions.